GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.6024 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.6024 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SOAT1, SOAT2, SRC, XDH |
15.3036 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AXL, BCL2, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SOAT1, SOAT2, SRC, TYR |
12.3203 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SOAT1, SOAT2 |
12.0445 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC, TYR |
11.8135 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC, TYR |
11.4673 |
[BP] GO:0007187 |
None
|
ADORA1, ADRB1, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
10.8544 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, KDR, MMP2, PIK3CA, PPARA, PTGS2, RORC, SRC, TYR |
10.6735 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, EGFR, ERBB2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
10.6006 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, PTGS2, RORC, SRC, TYR |
10.4502 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
9.68575 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
9.65261 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CNR1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FLT3, HSD11B2, HTR1B, HTR5A, PTGS2, RORC, SRC, TYR |
9.44956 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2C |
9.16981 |
[BP] GO:0003018 |
None
|
ADORA1, ADRB1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC |
9.16981 |
[BP] GO:0097746 |
None
|
ADORA1, ADRB1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
8.87414 |
[BP] GO:0035296 |
None
|
ADORA1, ADRB1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
8.87414 |
[BP] GO:0097756 |
None
|
ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
8.85372 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
8.72861 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, EGFR, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTGS2, SRC |
8.64322 |
[BP] GO:0050880 |
None
|
ADORA1, ADRB1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
8.61863 |
[BP] GO:0035150 |
None
|
ADORA1, ADRB1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
8.59297 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, HTR2B, HTR2C, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, SOAT1, SOAT2, TYR, XDH |
8.57882 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, F10, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
8.51927 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KDR, PTGS2, SRC |
8.5158 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB, SOAT1, SOAT2, SRC |
8.51351 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, F10, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
8.37735 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KDR, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TYR |
8.33761 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, ERBB2, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SOAT1, SOAT2 |
8.20818 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B2, SOAT1, SOAT2 |
8.16955 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CDC25B, CNR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SOAT1, SOAT2, SRC, TYR |
8.16187 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CYP1B1, DRD2, EGFR, ERBB2, ESR1, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
8.04817 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
7.98304 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
7.98304 |
[BP] GO:0007188 |
None
|
ADORA1, ADRB1, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
7.95952 |
[BP] GO:0003013 |
None
|
ADORA1, ADRB1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC |
7.94531 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, HTR2A, HTR2B, HTR2C, KDR, SRC |
7.88656 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2, DRD2, HTR1B |
7.86503 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
7.80759 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
7.73272 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CYP1B1, DRD2, EGFR, ERBB2, ESR1, ESRRA, F3, FABP3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, XDH |
7.66517 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, EGFR, ERBB2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
7.62743 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB, SOAT1, SOAT2 |
7.61168 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, EGFR, HTR1B, HTR2A, PTGS2 |
7.57084 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
7.56978 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CYP1A2, DRD1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, IGF1R, MMP2, PPARA, PTGS2, SRC |
7.32044 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
7.31483 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
7.31483 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
7.16904 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CNR1, CYP1B1, DRD2, EGFR, ERBB2, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
7.04823 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, PTGS2, SRC |
7.01021 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.95019 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRB1, CA2, CNR1, CNR2, DRD1, DRD2, ESR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, SRC |
6.81018 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HTR1B, HTR1D, KDR, SRC |
6.81018 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
6.75775 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, AXL, BCL2, CA1, CA2, CACNA1C, CNR1, CNR2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTPN1, RORC, SRC |
6.75766 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TYR, XDH |
6.75766 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, PPARA, PTGS2, SRC |
6.75307 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, EGFR, ERBB2, F10, F3, MET, PIK3CA, PIK3CB, SRC, XDH |
6.74187 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, HTR1A, SOAT1, SOAT2, TYR |
6.67521 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.53501 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, DRD2, EGFR, ERBB2, ESRRB, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.53501 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, DRD2, EGFR, ERBB2, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, PTGS2 |
6.52028 |
[BP] GO:0042310 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 |
6.46825 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F10, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC |
6.44869 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESRRB, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
6.32063 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
ERBB2, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
6.29895 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B, HTR2A, PTGS2 |
6.26795 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B, HTR2A, PTGS2 |
6.26795 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B2 |
6.16068 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.08197 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CACNA1C, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PIK3CA, PPARA, SRC, TYR |
6.0084 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.91772 |
[BP] GO:0007154 |
None
|
ADORA1, ADRB1, AXL, BCL2, CACNA1C, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2 |
5.87083 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, EGFR, ERBB2, ESR1, FABP4, FLT3, HTR1B, IGF1R, KDR, MMP2, PIK3CA, PTGS2, RORC, SRC |
5.84208 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.76806 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ERBB2, ESR1, FABP4, FLT3, HTR1B, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC |
5.76127 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F10, F3, MET, PIK3CA, PIK3CB, SRC |
5.74548 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F10, F3, HTR1D, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
5.73014 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, EGFR, HSD11B2, HTR1B, HTR2A, HTR2B, MMP2, PPARA, PTGS2, SRC, TYR |
5.72194 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
5.71514 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
5.70388 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CYP1B1, EGFR, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, XDH |
5.67714 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.65375 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTPN1, SRC, XDH |
5.64202 |
[BP] GO:0003008 |
None
|
ADORA1, ADRB1, AKR1B1, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, EGFR, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA, PTGS2, SOAT2, SRC, TYR |
5.6212 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, ALOX15, AURKB, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
5.61184 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CYP1B1, EGFR, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
5.61184 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC |
5.51095 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
5.47692 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2, RORC, SRC |
5.47475 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, ALOX15, AURKB, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
5.43098 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, AKR1B1, DRD1, DRD2, HTR2A, MET, PIK3CA |
5.42523 |
[BP] GO:0090066 |
None
|
ADORA1, ADRB1, ALOX15, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.40618 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CYP19A1, DRD1, DRD2, EGFR, ERBB2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC |
5.35379 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.35379 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.35379 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.34006 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2, SRC |
5.30933 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7 |
5.25974 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, ERBB2, PPARA |
5.22377 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, EGFR, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
5.19309 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
5.1054 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HTR5A, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TYR |
5.09702 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CYP1B1, EGFR, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
5.07138 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TYR, XDH |
5.06288 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.97762 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
4.94664 |
[BP] GO:0023052 |
None
|
ADORA1, ADRB1, CACNA1C, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.89402 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, CNR1, DRD2, HTR1B, HTR2A, MMP9, PTGS2 |
4.8939 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, ALOX15, AURKB, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
4.87887 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.79075 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, EGFR, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
4.77438 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, PIK3CB, PTPN1, SRC, XDH |
4.75185 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, EGFR, ERBB2, HTR2A, HTR2B, HTR2C, KDR, PTPN1, SRC |
4.74472 |
[BP] GO:0001659 |
None
|
ADORA1, ADRB1, DRD1, DRD2, HTR2A |
4.73089 |
[BP] GO:0008217 |
None
|
ADORA1, ADRB1, CNR1, DRD2, HSD11B2, PPARA, PTGS1, PTGS2 |
4.73028 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B2 |
4.6933 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
ERBB2, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.6933 |
[BP] GO:0007267 |
None
|
ADORA1, ADRB1, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.68112 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, EGFR, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC |
4.68045 |
[BP] GO:0042596 |
None
|
ADRB1, BCL2, DRD1, HTR1A, HTR2C |
4.67425 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.61895 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, HTR1B, PTGS2, SRC |
4.61895 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, BCL2, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.61455 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
ERBB2, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.58755 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, DRD2, EGFR, ERBB2, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SOAT1, SRC, XDH |
4.58297 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, HTR1B, PTGS2, SRC |
4.56813 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR1B, HTR2A |
4.55221 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, AURKB, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
4.53734 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.53476 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.53476 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.53182 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B2 |
4.53114 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
4.50862 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.50806 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, EGFR, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
4.50716 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ERBB2, ESR1, FLT3, HTR1A, MET, PIK3CB, PIM1, SRC, TYR |
4.4977 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, EGFR, PIK3CB, PTGS2 |
4.47904 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, FLT3, HTR2B, HTR2C, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
4.40459 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1, RORC |
4.38826 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, EGFR, ESR1, FABP3, HTR2A, HTR2B, HTR2C, PIK3CB |
4.38826 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, DRD2, EGFR, ERBB2, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.37582 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, HSD11B2, HTR1A, HTR2C, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SRC |
4.3391 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.33524 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC |
4.32938 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, AURKB, BCL2, CDC25B, CNR1, CNR2, DRD1, DRD2, EGFR, ERBB2, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.32007 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.27718 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, CNR2, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, HTR1B, HTR2A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
4.27464 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, CNR2, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, HTR1B, HTR2A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
4.25627 |
[BP] GO:0030258 |
lipid modification
|
CYP1A1, CYP3A4, EGFR, ERBB2, MET, PIK3CA, PIK3CB, SOAT1, SOAT2 |
4.24562 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 |
4.23961 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, PTGS2 |
4.23465 |
[BP] GO:0051952 |
None
|
ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR2A |
4.21079 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HTR1B, MMP2, MMP9, PTGS2 |
4.21079 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.19161 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, XDH |
4.15483 |
[BP] GO:0045776 |
None
|
ADORA1, ADRB1, CNR1, DRD2, PPARA |
4.15475 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A, TYR |
4.15405 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR1D, HTR2B |
4.14888 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.10618 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR2A, MMP9, PTGS2 |
4.10087 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, FLT3, HTR2B, HTR2C, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
4.09684 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, PIK3CA, PIK3CB, PTPN1, SRC |
4.06483 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.06183 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.05977 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC |
4.04987 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
4.04596 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.02246 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, HTR2A, HTR2B, IGF1R, PIK3CB, PTPN1, SRC |
4.02195 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CACNA1C, CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR2A, HTR2C |
4.00469 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
4.00469 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CYP1B1, DRD2, EGFR, ERBB2, ESR1, ESR2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.00469 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, HTR2A, HTR2B, PIK3CB, PTPN1, SRC |
3.9966 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, XDH |
3.97484 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
3.96638 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC |
3.96166 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, EGFR, HTR2A, HTR2B, HTR2C, KDR, SRC |
3.95495 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2, HTR1B |
3.94484 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, EGFR, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
3.94484 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC |
3.92184 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
3.92184 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, DRD1, EGFR, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.89799 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, AURKB, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, PPARA, PTGS2, RORC, SOAT1, SRC |
3.89799 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, EGFR, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.88675 |
[BP] GO:0007610 |
None
|
BCL2, CNR1, DRD1, DRD2, EGFR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
3.88675 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, XDH |
3.87902 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A, MET |
3.87459 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRB1, AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DRD1, DRD2, EGFR, ERBB2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MET, PIK3CA, PIK3CB, PTPN1, SRC |
3.85437 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ERBB2, ESR1, FABP4, FLT3, HTR1B, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, PTPN1, RORC, SRC |
3.82932 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, PIK3CA, PIK3CB, PTPN1, SRC |
3.82932 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, HTR2C, SRC |
3.81403 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, HTR1B, KDR, PTGS2, SRC |
3.79682 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, DRD2, EGFR, ESR1, HTR7, PPARA, RORC, SRC |
3.77333 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, DRD1, EGFR, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.76936 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.74154 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.73623 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRB1, AURKB, BCL2, CDC25B, CNR1, CNR2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, XDH |
3.70555 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
3.7021 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, EGFR, ESR1, F3, FABP4, KDR, MET, PPARA, PTGS2 |
3.7021 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC |
3.7021 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
ADRB1, BCL2, DRD1, HTR1A, HTR2C |
3.69084 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.68947 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, DRD1, EGFR, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.6727 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
3.67235 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
3.6516 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CACNA1C, CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, SRC |
3.64029 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
3.63334 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, PIK3CA, PIK3CB, PTPN1, SRC |
3.62273 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
3.62227 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
3.62227 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRB1, AURKB, BCL2, CDC25B, DRD2, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, XDH |
3.60813 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, DRD1, EGFR, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.5414 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, DRD1, EGFR, ERBB2, FLT3, HTR2B, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
3.52151 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, AURKB, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, MET, PPARA, PTGS2, RORC, SOAT1, SRC |
3.4766 |
[BP] GO:1900542 |
None
|
ADRB1, DRD1, DRD2, ESRRB, HTR1B, HTR1E, HTR2A, PPARA |
3.47148 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.4624 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRB1, CACNA1C, DRD1, DRD2, EGFR, HTR2B, HTR5A, KDR |
3.461 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
3.45362 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, DRD2, EGFR, ERBB2, FABP3, FABP4, MET, PIK3CA, PIK3CB |
3.44858 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.44683 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.44449 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, PTGS2, SRC |
3.4212 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TYR, XDH |
3.39625 |
[BP] GO:0006140 |
None
|
ADRB1, DRD1, DRD2, ESRRB, HTR1B, HTR1E, HTR2A, PPARA |
3.39596 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.37329 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
3.37329 |
[BP] GO:0060402 |
None
|
CACNA1C, DRD2, HTR2A, HTR2B, HTR2C |
3.37329 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, ALPL, AXL, BCL2, CDC25B, CYP1A1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRB, FABP4, FLT3, FUT7, HTR2B, KDR, MET, MMP2, MMP9, PTGS2, RORC, SOAT1, SOAT2, SRC |
3.3564 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
3.3558 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.3558 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.3558 |
[BP] GO:0051282 |
None
|
CACNA1C, DRD1, DRD2, HTR2A, HTR2B, HTR2C |
3.3558 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.3498 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, CACNA1C, DRD1, DRD2, EGFR, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.34872 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.34872 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CACNA1C, CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, SRC |
3.34803 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9 |
3.34104 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, EGFR, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.30678 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.28549 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR |
3.26668 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.25639 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CDC25B, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TYR, XDH |
3.25152 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR |
3.23786 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC |
3.23697 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B2, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TYR, XDH |
3.2115 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
EGFR, ESR1, HTR2A, HTR2B |
3.2115 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, PTGS1, PTGS2, SRC |
3.20937 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRB1, AURKB, BCL2, CDC25B, DRD2, EGFR, ERBB2, ESR1, F3, FLT3, HTR2A, HTR2B, PIK3CA, PIK3CB, PTPN1, SRC, XDH |
3.18745 |
[BP] GO:0002031 |
None
|
DRD2, HTR1B, HTR2B |
3.1668 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
3.16541 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, CNR1, EGFR, HTR2B, MET, PIK3CA, PPARA |
3.16493 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.16209 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
3.16156 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, HTR5A, PTGS2 |
3.16043 |
[BP] GO:0003012 |
None
|
ADORA1, DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
3.15842 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, DRD1, EGFR, ERBB2, FLT3, HTR2B, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
3.14942 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.14571 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, HTR2A, HTR2B, PIK3CB, PTPN1, SRC |
3.14571 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, AURKB, BCL2, CA9, CDC25B, CNR1, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
3.1369 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B2 |
3.1287 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.09699 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HTR1B, MMP2, MMP9, PTGS2 |
3.0948 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CNR1, CNR2, CYP1B1, DRD2, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
3.0948 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, AXL, BCL2, CA2, CACNA1C, CNR1, CYP1B1, DRD2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2B, HTR2C, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, SRC, XDH |
3.08662 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
EGFR, ESR1, HTR2A, HTR2B |
3.08569 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, EGFR, ESR1, FABP4, MMP2, PPARA, PTGS2, PTPN1, SRC |
3.06814 |
[BP] GO:0060401 |
None
|
CACNA1C, DRD2, HTR2A, HTR2B, HTR2C |
3.06814 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, PTGS1, PTGS2 |
3.04123 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGS2, SRC |
3.02708 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.02323 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
3.00311 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
3.00311 |
[BP] GO:0038128 |
None
|
EGFR, ERBB2, PIK3CA, SRC |
2.96263 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, DRD2, EGFR, HTR2A, PTGS2 |
2.952 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CACNA1C, CNR1, DRD2, EGFR, ERBB2, HTR2B, HTR2C, PTGS2, PTPN1, SRC |
2.94289 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.94024 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.92726 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2 |
2.91782 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.89922 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.87654 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRB1, ALOX15, AURKB, BCL2, CA9, CDC25B, CNR1, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
2.87001 |
[BP] GO:0006936 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
2.84649 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGS2, SRC |
2.84517 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, PPARA, PTGS2 |
2.84315 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, PTGS2, SRC |
2.82252 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CACNA1C, CDC25B, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
2.81263 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, PIK3CA, PIK3CB, PTGS2, SRC |
2.80928 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B |
2.80928 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, AURKB, BCL2, CA9, CDC25B, CNR1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
2.80771 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.80676 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, ESRRB, F3, HTR2A, HTR2B, KDR, MET, MMP9, PIM1, PTGS2, SRC |
2.80402 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, EGFR, HTR2B |
2.77605 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.76853 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR2C |
2.75285 |
[BP] GO:0009266 |
None
|
ADORA1, ADRB1, HTR1B, HTR2A, HTR2B, PTGS2 |
2.75264 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, HTR2A, HTR2B, IGF1R, PIK3CB, PTPN1, SRC |
2.75009 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.74402 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.74402 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR |
2.72059 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.72059 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.72059 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.72059 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.72059 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
2.67662 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.67662 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, ESR1, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.66079 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.65466 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 |
2.63392 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
2.61708 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.6127 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
EGFR, ESR1, HTR2A, HTR2B |
2.61131 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.58605 |
[BP] GO:0034435 |
None
|
SOAT1, SOAT2 |
2.58605 |
[BP] GO:0034433 |
None
|
SOAT1, SOAT2 |
2.58605 |
[BP] GO:0034434 |
None
|
SOAT1, SOAT2 |
2.58605 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.58605 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58605 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.58605 |
[BP] GO:0046854 |
phosphatidylinositol phosphorylation
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.58539 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, EGFR, ESR1, F3, FABP4, IGF1R, MET, MMP2, PPARA, PTGS2, PTPN1, SRC, XDH |
2.55031 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HTR2A, MET, SRC |
2.55031 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HTR2A, MET, SRC |
2.55031 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HTR2A, MET, SRC |
2.55031 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HTR2A, MET, SRC |
2.55031 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.53198 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.51739 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, AXL, CNR2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.51343 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, DRD2, EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.51343 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
2.50161 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
2.50161 |
[BP] GO:0055065 |
metal ion homeostasis
|
BCL2, CACNA1C, DRD1, DRD2, EGFR, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.50161 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CNR1, EGFR, ESRRB, HTR2A, HTR2B, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1 |
2.48141 |
[BP] GO:0007613 |
None
|
CNR1, DRD1, DRD2, HTR2A, PTGS2 |
2.48141 |
[BP] GO:0019725 |
cellular homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
2.48069 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A |
2.46077 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRB1, ALOX15, AURKB, BCL2, CA9, CDC25B, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
2.46043 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, HTR1B, HTR2B |
2.45227 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, EGFR, HTR2B |
2.45227 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, EGFR, HTR1A, PTGS2 |
2.43939 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.43453 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CACNA1C, CNR1, DRD2, EGFR, HTR2B, HTR2C, SRC |
2.4064 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.4064 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.4064 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.4064 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.39837 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, DRD1, EGFR, ERBB2, ESR1, FLT3, HTR1B, IGF1R, MMP2, PTGS2, SRC |
2.3875 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, PIK3CB, SRC, XDH |
2.38609 |
[BP] GO:0046834 |
lipid phosphorylation
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.38609 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRB1, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2C, KDR, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, XDH |
2.3854 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, DRD1, DRD2, HTR1A |
2.35528 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9 |
2.35204 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.35204 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, DRD2, ERBB2, ESR1, ESRRA, MMP2, PIK3CA, PIK3CB, PTPN1, SRC |
2.35005 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.3495 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
EGFR, ESR1, HTR2A, HTR2B |
2.3495 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, F10, F3, FLT3, FUT7, HTR1A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TYR, XDH |
2.33998 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.33998 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.33998 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33998 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.33998 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CACNA1C, CDC25B, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SRC, XDH |
2.31774 |
[BP] GO:0030814 |
None
|
ADRB1, DRD1, DRD2, HTR1B, HTR1E |
2.31317 |
[BP] GO:0051953 |
None
|
ADORA1, CNR1, DRD2 |
2.30924 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.30924 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30924 |
[BP] GO:0050890 |
None
|
ADORA1, CNR1, DRD1, DRD2, EGFR, HTR2A, PTGS2 |
2.2952 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, EGFR, ERBB2, HTR2B, PTGS2, SRC |
2.2952 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
EGFR, ESR1, HTR2A, HTR2B |
2.28253 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.26106 |
[BP] GO:0007202 |
None
|
EGFR, HTR2A, HTR2B |
2.26106 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.26106 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26106 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
2.25107 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CNR1, CYP1A1, EGFR, PTGS2, TYR |
2.24439 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, F3, FABP4, KDR, MET, PTGS2 |
2.23798 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.23491 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.21499 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SRC |
2.21204 |
[BP] GO:0006952 |
defense response
|
ADORA1, ADORA3, ALOX15, AXL, BCL2, CNR2, DRD1, HTR1A, HTR2C, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC |
2.19656 |
[BP] GO:0042632 |
None
|
FABP3, FABP4, SOAT1, SOAT2 |
2.19149 |
[BP] GO:0055092 |
None
|
FABP3, FABP4, SOAT1, SOAT2 |
2.19149 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
2.18918 |
[BP] GO:0009416 |
response to light stimulus
|
AURKB, BCL2, DRD1, DRD2, EGFR, PTGS2, TYR |
2.18918 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.18561 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
ADRB1, BCL2, DRD2, PIK3CA |
2.17233 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.17233 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2 |
2.17233 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ERBB2, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SOAT1, SRC, XDH |
2.16098 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.15923 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.15923 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.15923 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.15923 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.15923 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.15923 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AURKB, BCL2, CNR1, CNR2, DRD2, EGFR, ESR1, ESR2, ESRRA, FABP4, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, XDH |
2.1588 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, PPARA, SRC |
2.15818 |
[BP] GO:0046488 |
phosphatidylinositol metabolic process
|
DRD2, EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.13949 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.13147 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.13147 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, DRD1, DRD2, FABP3, HTR2A, HTR2B, HTR2C, PPARA |
2.12278 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, DRD1, EGFR, HTR1B, IGF1R, MMP2, PTGS2, SRC |
2.11633 |
[BP] GO:1903524 |
None
|
ADRB1, EGFR, HTR2A, PTGS2 |
2.11633 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, DRD1, EGFR, ERBB2, F10, FLT3, IGF1R, KDR, MET, SRC |
2.11139 |
[BP] GO:1900543 |
None
|
DRD2, HTR1B, HTR1E, PPARA |
2.0965 |
[BP] GO:0010507 |
negative regulation of autophagy
|
BCL2, HTR2B, MET, PIK3CA |
2.0965 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.0965 |
[BP] GO:0050873 |
None
|
ADRB1, FABP4, PTGS2 |
2.0965 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.0965 |
[BP] GO:0009411 |
response to UV
|
AURKB, BCL2, EGFR, PTGS2, TYR |
2.08762 |
[BP] GO:0042391 |
None
|
ADORA1, BCL2, CACNA1C, CNR1, CNR2, DRD1, KDR, SRC |
2.08762 |
[BP] GO:0045980 |
None
|
DRD2, HTR1B, HTR1E, PPARA |
2.07755 |
[BP] GO:0019637 |
organophosphate metabolic process
|
ACHE, ALOX15, DRD2, EGFR, ERBB2, HTR2B, HTR2C, MET, PIK3CA, PIK3CB, PTGS2, XDH |
2.07454 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, PTGS1, PTGS2 |
2.05796 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.05796 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CNR1, CNR2, CYP19A1, DRD2, ERBB2 |
2.05051 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, EGFR, HTR7, PPARA, RORC |
2.05045 |
[BP] GO:0030154 |
cell differentiation
|
ADRB1, ALPL, AXL, BCL2, CYP1A1, ERBB2, ESR1, FABP4, FLT3, FUT7, HTR2B, KDR, MMP2, MMP9, PTGS2, RORC, SOAT1, SOAT2 |
2.05045 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, DRD2, EGFR, HTR2A, HTR2C, PTGS2 |
2.04098 |
[BP] GO:0006644 |
phospholipid metabolic process
|
ACHE, ALOX15, DRD2, EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.03221 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.02331 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.02331 |
[BP] GO:0031214 |
biomineral tissue development
|
ALOX15, ALPL, PPARA, PTGS2 |
2.02331 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.02331 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.02331 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.02331 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.02331 |
[BP] GO:0014831 |
None
|
HTR1D, HTR2B |
2.02331 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.02331 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.02331 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.02331 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.02331 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, AXL, DRD2, PIK3CB, PTPN1, SRC |
2.01003 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, F10, F3, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SOAT1, SOAT2, SRC, TYR |
8.20912 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRB1, AXL, CA4, CNR1, CNR2, DRD1, DRD2, F10, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
7.88656 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRB1, ALOX15, AXL, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, DRD1, DRD2, EGFR, ERBB2, F10, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTGS2, SRC |
7.52663 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, F10, F3, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SOAT1, SOAT2, SRC, TYR |
7.4969 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, DRD1, DRD2, EGFR, ERBB2, ESR1, F10, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SRC |
7.01021 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
6.16836 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRB1, ALPL, AXL, CA12, CA14, CA4, CA9, CACNA1C, CNR1, CNR2, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, F10, F3, FLT3, FUT7, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SOAT1, SOAT2, TYR |
4.3471 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, F10, FLT3, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, PTPN1, SOAT1, SOAT2 |
3.68947 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, SOAT1, SOAT2 |
3.61937 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRB1, ALPL, AXL, CA12, CA14, CA9, CACNA1C, CNR1, CNR2, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SOAT1, SOAT2, TYR |
3.37329 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.46077 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2 |
2.31774 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CNR1, DRD1, DRD2, EGFR, ERBB2, HTR2A, MET, PTGS2, SRC |
2.23798 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CDC25B, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TYR, XDH |
2.05796 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CNR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B2, HTR2A, HTR4, HTR5A, KDR, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SOAT1, SOAT2, SRC, TYR, XDH |
2.05051 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.02331 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.6024 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.6024 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.5076 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.5076 |
[MF] GO:0008227 |
None
|
ADRB1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
15.8339 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TYR, XDH |
14.4429 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
14.3363 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC |
13.2574 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
12.7432 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
12.3406 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
12.2547 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC |
11.9268 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC |
11.5841 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
11.1009 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC |
10.8544 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.2133 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, TYR, XDH |
10.0446 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ERBB2, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
9.19059 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ERBB2, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
9.19059 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, RORC, SOAT1, SOAT2 |
7.70998 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CNR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC |
7.19636 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.9512 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, F10, F3, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SOAT1, SOAT2, SRC, TYR, XDH |
6.6529 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.32063 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.98061 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, NQO2, PTGS1, PTGS2, SOAT1, SOAT2, SRC, XDH |
5.89763 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRB1, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
5.85937 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, PPARA, RORC, SOAT1, SOAT2 |
5.79379 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
5.59105 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC |
5.56006 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.47937 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.35055 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.35055 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.21359 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.21359 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC |
5.19213 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.09702 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC |
4.95793 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.7652 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, TYR |
4.61895 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRB1, AOX1, AURKB, AXL, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, XDH |
4.29159 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.18538 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.02395 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B2, XDH |
3.95495 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, TYR, XDH |
3.73623 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.72744 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.44683 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.41083 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.41083 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
3.32329 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
3.23786 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.2115 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.1668 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
3.11574 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
3.00311 |
[MF] GO:0034736 |
None
|
SOAT1, SOAT2 |
3.00311 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.00311 |
[MF] GO:0004772 |
None
|
SOAT1, SOAT2 |
3.00311 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
3.00311 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
3.00311 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.77605 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.58605 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.58605 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.58605 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PPARA, PTPN1 |
2.5673 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
2.53367 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.48811 |
[MF] GO:1901338 |
None
|
ADRB1, DRD1, DRD2 |
2.46077 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, AURKB, AXL, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, XDH |
2.46035 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC |
2.45227 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.33998 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.33998 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.33998 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PTPN1 |
2.28386 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B2 |
2.26846 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SRC |
2.20294 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.18678 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, PTGS2 |
2.17233 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.15923 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.15923 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B2 |
2.13491 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, PTGS2 |
2.13491 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, BCL2, DRD2, EGFR, ERBB2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP9, NQO2, PTGS2, TYR, XDH |
2.08762 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B2 |
2.05796 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.02331 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.02331 |